Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Nerve Blocks in Infant Aortic Coarctation Repair
NCT03408340Phase 4Terminated
- Sponsor
- Emory University
- Start
- Jul 2018
- Primary completion
- Jul 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in pain (2 arms), sponsored by Emory University. Primary endpoint: Morphine Equivalents at 48 hours. Started Jul 2018; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT03408340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408340.